Amexdrug
(OTC) AXRX
Amexdrug Financials at a Glance
Market Cap
$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$2.96M
Net Income (TTM)
$51.26K
EPS (TTM)
$0.00
P/E Ratio
0.67
Dividend
$0.00
Beta (Volatility)
23.72 (High)
Dividend
$0.00
Beta (Volatility)
23.72 (High)
Price
$0.00
Volume
2,200
Open
$0.00
Price
$0.00
Volume
2,200
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
23.72 (High)
Price
$0.00
Volume
2,200
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
N/A
AXRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amexdrug
Industry
Healthcare Providers and Services
Sector
Health CareCEO
Jack N. Amin
Website
www.amexdrug.comHeadquarters
Commerce, CA 90040, US
AXRX Financials
Key Financial Metrics (TTM)
Gross Margin
45.96%
Operating Margin
4.94%
Net Income Margin
1.73%
Return on Equity
2.84%
Return on Capital
6.12%
Return on Assets
2.13%
Earnings Yield
1.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
169.41M
Volume
2.20K
Avg. Volume
105.274
Financials (TTM)
Gross Profit
$1.36M
Operating Income
$146.33K
EBITDA
$146.33K
Operating Cash Flow
$146.60
Capital Expenditure
$0.00
Free Cash Flow
$146.60
Cash & ST Invst.
$1.67M
Total Debt
$422.55K
Amexdrug Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$736.56K
-8.4%
Gross Profit
$408.96K
+726.0%
Gross Margin
55.52%
N/A
Market Cap
$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.77K
N/A
Employees
9
N/A
Net Income
$20.97K
+156.6%
EBITDA
$47.37K
+1452.1%
Quarterly Fundamentals
Total Cash
$1.67M
+1.0%
Total Debt
$422.55K
-8.8%
Accounts Receivable
$37.49K
-76.1%
Inventory
$554.36K
-3.8%
Long Term Debt
$422.55K
-8.8%
Short Term Debt
$0.00
N/A
Return on Assets
2.13%
N/A
Return on Invested Capital
6.51%
N/A
Free Cash Flow
$146.60
N/A
Operating Cash Flow
$146.60
N/A